These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 31580163)

  • 1. Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders.
    Leitner GR; Wenzel TJ; Marshall N; Gates EJ; Klegeris A
    Expert Opin Ther Targets; 2019 Oct; 23(10):865-882. PubMed ID: 31580163
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases.
    Li L; Acioglu C; Heary RF; Elkabes S
    Brain Behav Immun; 2021 Jan; 91():740-755. PubMed ID: 33039660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases.
    Sharma V; Sharma P; Singh TG
    Pharmacol Rep; 2024 Aug; 76(4):679-692. PubMed ID: 38918327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
    Bisogno T; Di Marzo V
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Toll-Like Receptor (TLR) Signaling Pathway by Polyphenols in the Treatment of Age-Linked Neurodegenerative Diseases: Focus on TLR4 Signaling.
    Azam S; Jakaria M; Kim IS; Kim J; Haque ME; Choi DK
    Front Immunol; 2019; 10():1000. PubMed ID: 31134076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation.
    Rahimifard M; Maqbool F; Moeini-Nodeh S; Niaz K; Abdollahi M; Braidy N; Nabavi SM; Nabavi SF
    Ageing Res Rev; 2017 Jul; 36():11-19. PubMed ID: 28235660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation.
    Baby N; Patnala R; Ling EA; Dheen ST
    Curr Med Chem; 2014; 21(37):4215-26. PubMed ID: 25039775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal heat shock protein 60 mediates neurodegeneration and demyelination in the CNS through a TLR4- and MyD88-dependent pathway.
    Rosenberger K; Dembny P; Derkow K; Engel O; Krüger C; Wolf SA; Kettenmann H; Schott E; Meisel A; Lehnardt S
    Mol Neurodegener; 2015 Feb; 10():5. PubMed ID: 25887709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors in the pathogenesis of neuroinflammation.
    Kumar V
    J Neuroimmunol; 2019 Jul; 332():16-30. PubMed ID: 30928868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
    Downer EJ; Johnston DG; Lynch MA
    Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide induced altered signaling pathways in various neurological disorders.
    Singh S; Sahu K; Singh C; Singh A
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Mar; 395(3):285-294. PubMed ID: 34989812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
    Rajalakshmy AR; Malathi J; Madhavan HN
    PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential.
    Dabi YT; Ajagbe AO; Degechisa ST
    Immun Inflamm Dis; 2023 Apr; 11(4):e839. PubMed ID: 37102648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia are required for astroglial Toll-like receptor 4 response and for optimal TLR2 and TLR3 response.
    Holm TH; Draeby D; Owens T
    Glia; 2012 Apr; 60(4):630-8. PubMed ID: 22271465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-κB pathway in rats.
    Zhou J; Deng Y; Li F; Yin C; Shi J; Gong Q
    Biomed Pharmacother; 2019 Mar; 111():315-324. PubMed ID: 30590319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
    Derkow K; Krüger C; Dembny P; Lehnardt S
    PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome c can be released into extracellular space and modulate functions of human astrocytes in a toll-like receptor 4-dependent manner.
    Wenzel TJ; Bajwa E; Klegeris A
    Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129400. PubMed ID: 31344401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Toll-like receptor/MYD88 signaling in neurodegenerative diseases.
    Xiang W; Chao ZY; Feng DY
    Rev Neurosci; 2015; 26(4):407-14. PubMed ID: 25870959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.